SVRA EBITDA | Savara Inc

Savara Inc (SVRA) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$40.97M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$38.99M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA -$30.22M*; Operating income -$30.25M; Depreciation and amortization $35.00K*.
2025-06-30: Basis Reported; EBITDA (m); Operating income -$31.44M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2011-12-31 to 2020-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$40.97M	(m)	(m)	(m)	$222.00K*	-$29.75M*	(m)	(m)	(m)	(m)
2026-03-31	Reported	(m)	-$38.99M	(m)	(m)	(m)	$54.00K	-$33.05M	(m)	(m)	(m)	(m)
2025-09-30	Reported	-$30.22M*	-$30.25M	$35.00K*	(m)	(m)	$2.00K*	-$22.53M*	(m)	(m)	(m)	(m)
2025-06-30	Reported	(m)	-$31.44M	(m)	(m)	(m)	$15.00K*	-$26.26M*	(m)	(m)	(m)	(m)
2025-03-31	Reported	(m)	-$28.43M	(m)	(m)	(m)	$3.00K	-$27.19M	(m)	(m)	(m)	(m)
2024-09-30	Reported	-$26.32M*	-$26.36M	$33.00K*	(m)	(m)	$3.00K*	-$22.67M*	(m)	(m)	(m)	(m)
2024-06-30	Reported	(m)	-$23.19M	(m)	(m)	(m)	$21.00K*	-$22.50M*	(m)	(m)	(m)	(m)
2024-03-31	Reported	(m)	-$22.48M	(m)	(m)	(m)	$10.00K	-$20.64M	(m)	(m)	(m)	(m)
2023-09-30	Reported	(m)	-$18.04M	(m)	(m)	(m)	$43.00K*	-$13.16M*	(m)	(m)	(m)	(m)
2023-06-30	Reported	(m)	-$12.22M	(m)	(m)	(m)	$225.00K*	-$10.27M*	(m)	(m)	(m)	(m)
2023-03-31	Reported	(m)	-$12.11M	(m)	(m)	(m)	$4.00K	-$12.03M	(m)	(m)	(m)	(m)
2022-09-30	Reported	(m)	-$10.54M	(m)	(m)	(m)	$4.00K*	-$8.16M*	(m)	(m)	(m)	(m)
2022-06-30	Reported	(m)	-$9.38M	(m)	(m)	(m)	(m)	-$9.32M*	(m)	(m)	(m)	(m)
2022-03-31	Reported	(m)	-$8.05M	(m)	(m)	(m)	(m)	-$8.43M	(m)	(m)	(m)	(m)
2021-09-30	Reported	(m)	-$9.97M	(m)	$0.00	(m)	$11.00K*	-$8.93M*	(m)	(m)	(m)	(m)
2021-06-30	Reported	(m)	-$10.45M	(m)	(m)	(m)	(m)	-$12.19M*	(m)	(m)	(m)	(m)
2021-03-31	Reported	(m)	-$10.41M	(m)	(m)	(m)	(m)	-$9.60M	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	-$10.79M	(m)	$256.00K	(m)	$18.00K*	-$6.71M*	(m)	(m)	(m)	(m)
2020-06-30	Reported	-$9.05M*	-$9.26M	$213.00K*	$0.00*	(m)	$20.00K*	-$7.75M*	(m)	(m)	(m)	(m)
2020-03-31	Reported	-$16M	(m)	(m)	(m)	(m)	$4.00K	-$13.08M	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$31.27M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	-$12.21M*	-$12.44M	$233.00K*	$0.00*	(m)	$6.00K*	-$11.41M*	(m)	(m)	(m)	(m)
2019-06-30	Reported	-$21.92M*	-$22.15M	$232.00K*	$0.00*	(m)	$36.00K*	-$12.90M*	(m)	(m)	(m)	(m)
2019-03-31	Reported	-$12.61M	(m)	(m)	(m)	(m)	$96.00K	-$10.86M	(m)	$1.40M	(m)	(m)
2018-12-31	Reported	-$13.11M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$2.50M
2018-09-30	Reported	-$12.66M*	-$12.78M	$127.00K*	(m)	(m)	$16.00K*	-$8.76M*	(m)	(m)	(m)	-$110.00K
2018-06-30	Reported	-$11.75M*	-$11.91M	$153.00K*	(m)	(m)	$46.00K*	-$10.35M*	(m)	(m)	(m)	-$277.00K
2018-03-31	Reported	-$32M	(m)	(m)	(m)	(m)	$19.00K	-$9.67M	(m)	(m)	(m)	-$4.55M
2017-12-31	Reported	(m)	-$9.30M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$6.54M	(m)	(m)	(m)	$1.00K*	-$8.25M*	(m)	(m)	(m)	-$117.00K
2017-06-30	Reported	(m)	-$9.34M	(m)	(m)	(m)	$1.00K*	(m)	(m)	(m)	(m)	-$470.00K
2017-03-31	Reported	(m)	-$4.77M	(m)	(m)	(m)	$59.00K	(m)	(m)	(m)	$1.58M	-$237.00K
2016-12-31	Reported	(m)	-$4.04M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$3.23M	(m)	(m)	(m)	$3.00K*	(m)	(m)	(m)	$2.13M	(m)
2016-06-30	Reported	(m)	-$1.98M	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)	$2.44M	(m)
2016-03-31	Reported	(m)	-$1.69M	(m)	(m)	(m)	$5.00K	(m)	(m)	(m)	$2.83M	(m)
2015-12-31	Reported	(m)	-$9.71M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	(m)	-$9.83M	(m)	(m)	(m)	$27.00K*	(m)	(m)	(m)	$2.46M	(m)
2015-06-30	Reported	(m)	-$10.18M	(m)	(m)	(m)	$21.00K*	(m)	(m)	(m)	$2.41M	(m)
2015-03-31	Reported	(m)	-$9.65M	(m)	(m)	(m)	$70.00K	(m)	(m)	(m)	$3.58M	(m)
2014-12-31	Reported	(m)	-$7.35M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	(m)	-$7.88M	(m)	(m)	(m)	$28.00K*	(m)	(m)	(m)	$2.46M	(m)
2014-06-30	Reported	(m)	-$7.20M	(m)	(m)	(m)	$103.00K*	(m)	(m)	(m)	$2.37M	(m)
2014-03-31	Reported	-$6.83M	(m)	(m)	(m)	(m)	$6.00K	-$6.27M	(m)	(m)	$2.27M	(m)
2013-12-31	Reported	-$5.71M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$5.26M*	-$5.27M	$10.06K*	(m)	(m)	$28.17K*	-$3.77M*	(m)	(m)	$2.16M	(m)
2013-06-30	Reported	-$4.94M*	-$4.95M	$8.88K*	(m)	(m)	$12.45K*	-$4.67M*	(m)	(m)	$2.10M	(m)
2013-03-31	Reported	-$5.58M	(m)	(m)	(m)	(m)	$4.72K	-$4.49M	(m)	(m)	$2.11M	(m)
2012-12-31	Reported	-$4M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$3.21M*	-$3.22M	$10.64K*	(m)	(m)	$4.99K*	-$3.17M*	(m)	(m)	$1.82M	(m)
2012-06-30	Reported	-$4.18M*	-$4.22M	$36.74K*	(m)	(m)	$18.55K*	-$2.94M*	(m)	(m)	$1.87M	(m)
2012-03-31	Reported	-$4.14M	(m)	(m)	(m)	(m)	$187.36K	-$4.46M	(m)	(m)	$2.05M	(m)
2011-12-31	Reported	(m)	-$2.44M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	(m)	-$3.55M	(m)	(m)	(m)	$184.44K*	-$3.47M*	(m)	(m)	$1.98M	(m)
2011-06-30	Reported	(m)	-$4.41M	(m)	(m)	(m)	$9.68K*	-$4.59M*	(m)	(m)	$1.82M	(m)
2011-03-31	Reported	(m)	-$2.99M	(m)	(m)	(m)	$14.86K	-$2.38M	(m)	(m)	$1.57M	(m)
2010-09-30	Reported	(m)	-$1.87M	(m)	(m)	(m)	$0.00*	-$1.83M*	(m)	(m)	$944.95K	(m)
2010-06-30	Reported	(m)	-$1.94M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	$1.30M	(m)

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$123.55M	(m)	(m)	(m)	$22.00K	-$101.04M	(m)	(m)	(m)	$0.00
2024-12-31	Reported	(m)	-$103.20M	(m)	(m)	(m)	$25.00K	-$89.09M	(m)	(m)	(m)	$9.00K
2023-12-31	Reported	(m)	-$60.01M	(m)	(m)	(m)	$296.00K	-$51.06M	(m)	(m)	(m)	(m)
2022-12-31	Reported	(m)	-$38.84M	(m)	(m)	(m)	$9.00K	-$34.55M	(m)	(m)	(m)	(m)
2021-12-31	Reported	(m)	-$41.48M	(m)	(m)	(m)	$57.00K	-$40.08M	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	-$49.30M	(m)	$257.00K	(m)	$47.00K	-$39.84M	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	-$67.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$69.45M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$82.34M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$78.02M	(m)	(m)	(m)	(m)	$148.00K	-$45.12M	(m)	(m)	(m)	(m)
2019-12-31	Rolling	(m)	-$79.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$60.76M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$61.11M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$50.86M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	-$69.52M	(m)	(m)	(m)	(m)	$141.00K	-$39.27M	(m)	(m)	(m)	-$7.06M
2018-12-31	Rolling	(m)	-$70.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	-$2.44M*
2018-09-30	Rolling	(m)	-$66.09M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$59.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$57.29M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	-$29.96M	(m)	(m)	(m)	$495.00K	-$28.23M	(m)	(m)	(m)	-$3.63M
2017-12-31	Rolling	(m)	-$29.96M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$24.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$21.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$14.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$10.95M	(m)	(m)	(m)	$8.00K	(m)	(m)	(m)	$9.34M	-$357.00K
2016-12-31	Rolling	(m)	-$10.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$16.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$23.22M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$31.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	(m)	-$5.92M	(m)	(m)	(m)	$165.00K	(m)	(m)	(m)	$10.96M	$0.00
2015-12-31	Rolling	(m)	-$39.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$37.01M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$35.07M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$32.09M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	(m)	-$29.28M	(m)	(m)	(m)	$147.00K	(m)	(m)	(m)	$9.49M	$0.00
2014-12-31	Rolling	(m)	-$29.28M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$27.65M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$25.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$22.79M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$21.5M	(m)	(m)	(m)	(m)	$47.00K	-$17.79M	(m)	(m)	$8.52M	$0.00
2013-12-31	Rolling	(m)	-$21.54M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$19.83M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$17.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$17.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$15.54M	(m)	(m)	(m)	(m)	$266.18K	-$13.92M	(m)	(m)	$7.52M	(m)
2012-12-31	Rolling	(m)	-$15.63M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	-$14.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Rolling	(m)	-$14.39M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	-$14.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$13.36M	(m)	(m)	(m)	(m)	$411.76K	-$13.47M	(m)	(m)	$7.19M	(m)
2011-12-31	Rolling	(m)	-$13.40M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	(m)	-$8.54M	(m)	(m)	(m)	$28.51K	-$8.34M	(m)	(m)	$4.99M	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
MoonLake Immunotherapeutics (MLTX)	Switzerland	$1.031B	-5.43
MANNKIND CORP (MNKD)	United States	$1.058B	-30.41
Alto Neuroscience, Inc. (ANRO)	United States	$1.065B	-11.02
Pacira BioSciences, Inc. (PCRX)	United States	$1.020B	69.03
Janux Therapeutics, Inc. (JANX)	United States	$1.019B	-9.15
Corvus Pharmaceuticals, Inc. (CRVS)	United States	$0.994B	-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)	United States	$1.116B	10.93
Kura Oncology, Inc. (KURA)	United States	$0.967B	-3.29
Arbutus Biopharma Corp (ABUS)		$0.965B	6.19
Seaport Therapeutics, Inc. (SPTX)	United States	$1.131B